Previous close | 0.5109 |
Open | 0.5250 |
Bid | 0.5040 x 1100 |
Ask | 0.5199 x 4000 |
Day's range | 0.5000 - 0.5250 |
52-week range | 0.2500 - 0.9100 |
Volume | |
Avg. volume | 1,013,911 |
Market cap | 33.787M |
Beta (5Y monthly) | 1.77 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
POTOMAC, Md., April 16, 2024--IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two.
POTOMAC, Md., April 09, 2024--IGC Pharma Adds Advisor in Artificial Intelligence
POTOMAC, Md., March 26, 2024--IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock